Lipid-Lowering Medications are Associated with Reduced Sarcopenia-Related Quality of Life in Older Adults with Hyperlipidemia.

Rizwan QaisarImran M KhanAsima KarimTahir MuhammadFirdos Ahmad

Published in: Drugs & aging (2024)

Collectively, statin usage was associated with NMJ degradation and reduced SarQoL. Statins should be cautiously prescribed in patients with sarcopenia with reduced QoL.

Keyphrases

cardiovascular disease
skeletal muscle
physical activity
coronary artery disease
community dwelling
fatty acid
metabolic syndrome